Lansoprazole
- Product NDC
- 46122-744
- 11-digit product format
- 461220744
- Labeler code
- 46122
- Product ID
- 46122-744_756f298d-53bd-cd28-216c-4e7d886fdee3
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AMERISOURCEBERGEN DRUG CORPORATION
- Application
- ANDA202194
- Marketing category
- ANDA
- Marketing start
- 2022-04-12
- Substance
- LANSOPRAZOLE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lansoprazole
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LANSOPRAZOLE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0K5C5T2QPG |
| Rxcui | 596843 |
DailyMed Product Concepts#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 46122-744 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [AMERISOURCEBERGEN DRUG CORPORATION] | 2 | Current NDC | 20241203_accb92e8-dd14-b87b-c20a-6c4803815bc2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 46122-744-04 | 46122074404 | 3 BOTTLE in 1 CARTON (46122-744-04) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 3 bottle | 2023-08-30 | | No | No | Current |
| 46122-744-74 | 46122074474 | 1 BOTTLE in 1 CARTON (46122-744-74) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE | 1 bottle | 2023-08-30 | 2026-08-31 | No | No | Historical |